12/17
04:15 pm
nbtx
NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
Low
Report
NANOBIOTIX to Introduce Vision for Transforming Drug Design and Development with Next Nanotherapeutic Platform on 19 December 2024
12/11
04:15 pm
nbtx
Voting Rights and Shares Capital of the Company
Medium
Report
Voting Rights and Shares Capital of the Company
12/9
04:15 pm
nbtx
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
Medium
Report
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
11/13
04:15 pm
nbtx
Voting Rights and Shares Capital of the Company
Medium
Report
Voting Rights and Shares Capital of the Company
11/12
02:30 am
nbtx
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
Low
Report
NANOBIOTIX Provides Third Quarter 2024 Update and Progress on Nanotherapeutics Platforms
10/31
03:30 am
nbtx
NANOBIOTIX to Participate in Multiple Investor Conferences in November
Medium
Report
NANOBIOTIX to Participate in Multiple Investor Conferences in November
10/11
04:15 pm
nbtx
Voting Rights and Shares Capital of the Company
Low
Report
Voting Rights and Shares Capital of the Company